Bullish Moving Averages
0
Bearish Moving Averages
16
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
339.60Today’s High
348.0052W low
294.4052W High
558.00Open Price
347.40Prev. Close
357.3000Volume
1910287.00Value
649688608.70Fundamentals
Market Cap
16988.40
Price to Earnings
131.40
Price to Book Value
3.40
Dividend Yield
34.70
PE to Growth
-1.90
Op Revenue TTM
11216.20
Net Profit TTM
129.29
Cash From Operating Activity
157.81
Return on Equity %
2.83
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
67
Week
61.4
Month
67.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
342.57
PIVOT
First Resistance
345.53
Second Resistance
350.97
Third Resistance
353.93
First Support
337.13
Second Support
334.17
Third Support
328.73
Relative Strength Index
38.35
Money Flow Index
71.47
MACD
-5.19
MACD Signal
-4.5
Average True Range
11.74
Average Directional Index
10.77
Rate of Change (21)
0.89
Rate of Change (125)
-14.62
Commodity Channel Index
-143.9
Williams %R
-99
BETA
1 Month
0.47
3 Month
0.51
1 Year
0.39
3 Year
0.17
PRICE CHANGE ANALYSIS
↓ -1.89%
1 Week
Low
High
339.6
353.95
↓ -4.81%
1 Month
Low
High
339.6
387.7
↓ -25.54%
3 Months
Low
High
311.1
558
↓ -18.53%
6 Months
Low
High
311.1
558
↑ 9.43%
1 Year
Low
High
294.35
558
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 549.28 | 537.83 | 529.69 | 468.72 | 441.69 | 409.33 | 395.73 | 336.76 | 345.33 | 301.90 | 291.92 | |
| Operating Expenses Qtr | 446.06 | 433.00 | 423.15 | 374.21 | 344.00 | 328.00 | 301.42 | 271.93 | 246.79 | 245.96 | 241.43 | |
| Operating Profit Qtr | 99.50 | 91.50 | 86.06 | 83.02 | 85.46 | 70.64 | 76.54 | 55.75 | 44.00 | 49.06 | 37.11 | |
| EBIDT Qtr Cr | 103.22 | 104.83 | 106.54 | 94.51 | 97.69 | 81.33 | 94.31 | 64.83 | 98.54 | 55.94 | 50.49 | |
| Depreciation Qtr | 35.65 | 30.55 | 29.13 | 26.05 | 29.06 | 25.71 | 25.28 | 23.97 | 24.47 | 24.75 | 24.85 | |
| Net Profit Qtr | -8.11 | 53.19 | 59.06 | 52.82 | 51.87 | 34.58 | 56.96 | 29.88 | 62.87 | 19.34 | 15.39 | |
| Basic EPS Qtr | -0.16 | 1.07 | 1.19 | 1.06 | 1.04 | 0.70 | 1.15 | 0.60 | 1.26 | 0.39 | 0.46 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 2085.52 | 1583.51 | 1198.67 | 768.17 | 874.93 | |
| Operating Expenses Annual Cr | 1676.42 | 1245.35 | 965.97 | 704.71 | 687.80 | |
| Operating Profit Annual | 360.08 | 288.39 | 150.50 | 41.83 | 72.62 | |
| Operating Profit Margin Annual % | 17.27 | 18.21 | 12.56 | 5.45 | 8.30 | |
| Total Expenses Annual Cr | 1876.17 | 1401.18 | 1108.71 | 836.21 | 810.32 | |
| EBIDT Annual Cr | 409.10 | 338.16 | 232.70 | 63.46 | 187.13 | |
| EBIDT Annual margin % | 19.62 | 21.36 | 19.41 | 8.26 | 21.39 | |
| Depreciation | 121.38 | 104.02 | 98.72 | 95.00 | 89.32 | |
| PAT Before ExtraOrdinary Items Annual Cr | 156.96 | 173.29 | 90.18 | -68.78 | 60.61 | |
| Net Profit Annual | 156.96 | 173.29 | 90.18 | -68.78 | 60.61 | |
| Basic EPS Annual | 3.15 | 3.48 | 1.81 | -1.38 | 1.21 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3294.24 | 2756.18 | 2955.21 | 2864.11 | 2556.22 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 779.69 | 565.85 | 463.95 | 396.70 | 359.81 | |
| Total Current Liabilities Annual Cr | 463.80 | 405.66 | 342.84 | 327.81 | 262.59 | |
| Total Capital Plus Liabilities Annual Cr | 4537.73 | 4102.07 | 3762.00 | 3588.62 | 3553.00 | |
| Fixed Assets Annual | 1371.71 | 1074.84 | 1036.17 | 1019.80 | 1035.98 | |
| Total Non Current Assets Annual | 2767.89 | 3787.19 | 3562.22 | 3390.37 | 3379.91 | |
| Total Current Assets Annual | 1769.84 | 314.88 | 199.78 | 198.25 | 173.09 | |
| Total Assets Annual | 4537.73 | 4102.07 | 3762.00 | 3588.62 | 3553.00 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 490.33 | 397.24 | 323.87 | 248.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 412.75 | 245.86 | 31.94 | 41.66 | 98.00 | |
| Cash from Investing Activity Annual | -342.32 | -331.95 | -3.35 | -38.07 | 39.75 | |
| Cash from Financing Annual Activity | -67.09 | 92.20 | -17.11 | -12.35 | -125.70 | |
| Net Cash Flow Annual | - | 6.11 | 11.48 | -8.76 | 12.05 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 65.95 | 55.18 | 59.43 | 57.62 | 51.17 | |
| ROE Annual % | 4.76 | 6.28 | 3.05 | -2.40 | 2.37 | |
| ROCE Annual % | 7.06 | 6.33 | 3.91 | -0.96 | 2.97 | |
| Total Debt to Total Equity Annual | 0.12 | 0.12 | 0.07 | 0.05 | 0.05 | |
| EBDIT Annual Margin % | 20.08 | 22.04 | 20.84 | 8.50 | 24.60 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 977.67 | 3718.56 | 3325.22 | 3224.57 | 3276.35 | 3200.67 | 2834.72 | 2699.39 | 2749.77 | 2661.09 | 2513.45 | |
| Operating Expenses Qtr | 814.25 | 3146.47 | 2939.36 | 2827.66 | 2756.73 | 2743.47 | 2497.39 | 2370.02 | 2265.26 | 2252.50 | 2161.53 | |
| Operating Profit Qtr | 159.34 | 564.14 | 377.27 | 387.71 | 505.59 | 448.67 | 318.91 | 292.10 | 462.53 | 397.06 | 342.81 | |
| EBIDT Qtr Cr | 119.50 | 572.09 | 331.24 | 396.91 | 519.62 | 457.20 | 337.33 | 329.37 | 484.51 | 408.59 | 351.92 | |
| Depreciation Qtr | 58.36 | 231.54 | 227.16 | 217.46 | 218.60 | 197.51 | 189.37 | 174.96 | 170.37 | 160.88 | 156.35 | |
| Net Profit Qtr | -24.03 | 179.21 | -30.79 | 4.90 | 170.77 | 139.39 | 46.21 | 68.54 | 226.27 | 148.34 | 106.91 | |
| Basic EPS Qtr | -0.48 | 3.60 | -0.62 | 0.10 | 3.43 | 2.80 | 0.93 | 1.38 | 4.55 | 2.98 | 2.15 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 3723.75 | 12011.13 | 10303.94 | 8658.40 | 8776.37 | |
| Operating Expenses Annual Cr | 3120.95 | 10367.61 | 8770.03 | 7545.64 | 7480.89 | |
| Operating Profit Annual | 577.95 | 1565.27 | 1483.25 | 1062.79 | 1257.61 | |
| Operating Profit Margin Annual % | 15.52 | 13.03 | 14.39 | 12.27 | 14.33 | |
| Total Expenses Annual Cr | 3451.22 | 11477.27 | 9667.63 | 8456.87 | 8426.50 | |
| EBIDT Annual Cr | 602.80 | 1643.52 | 1533.91 | 1112.76 | 1295.48 | |
| EBIDT Annual margin % | 16.19 | 13.68 | 14.89 | 12.85 | 14.76 | |
| Depreciation | 219.97 | 780.44 | 640.58 | 617.57 | 585.94 | |
| PAT Before ExtraOrdinary Items Annual Cr | 216.02 | 474.27 | 600.51 | 174.31 | 314.85 | |
| Net Profit Annual | 129.28 | 424.91 | 525.99 | 147.74 | 276.61 | |
| Basic EPS Annual | 2.60 | 8.53 | 10.57 | 2.97 | 5.50 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 4559.79 | 4073.69 | 3953.41 | 3372.46 | 2897.76 | |
| Minority Interest Liability Annual Cr | 470.32 | 412.39 | 529.21 | 461.66 | 446.37 | |
| Total Non Current Liabilities Annual Cr | 1672.94 | 5365.46 | 4505.04 | 4613.72 | 4997.25 | |
| Total Current Liabilities Annual Cr | 11288.26 | 4655.28 | 3558.58 | 3195.62 | 3722.08 | |
| Total Capital Plus Liabilities Annual Cr | 17991.31 | 14881.20 | 12546.24 | 11643.46 | 12437.84 | |
| Fixed Assets Annual | 3081.33 | 8171.70 | 6918.46 | 6630.55 | 6790.82 | |
| Total Non Current Assets Annual | 3826.01 | 9959.64 | 8449.78 | 8014.45 | 8342.17 | |
| Total Current Assets Annual | 14165.30 | 4921.56 | 4096.46 | 3629.01 | 4095.67 | |
| Total Assets Annual | 17991.31 | 14881.20 | 12546.24 | 11643.46 | 12437.84 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 365.46 | 381.30 | 299.39 | 287.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 157.81 | 1833.98 | 1313.46 | 1569.12 | 1223.25 | |
| Cash from Investing Activity Annual | -884.65 | -971.88 | -570.48 | -330.30 | -667.28 | |
| Cash from Financing Annual Activity | 1052.83 | -817.39 | -685.42 | -1116.13 | -674.80 | |
| Net Cash Flow Annual | 325.99 | 44.71 | 57.56 | 122.69 | -118.83 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 100.70 | 89.81 | 90.15 | 77.14 | 66.95 | |
| ROE Annual % | 2.83 | 10.43 | 13.30 | 4.38 | 9.54 | |
| ROCE Annual % | 5.71 | 8.44 | 9.93 | 5.86 | 8.14 | |
| Total Debt to Total Equity Annual | 0.15 | 0.56 | 0.55 | 0.57 | 0.86 | |
| EBDIT Annual Margin % | 16.29 | 13.77 | 14.96 | 12.92 | 14.82 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Hdfc Small Cap Fund | 4.96 | 75066703 | - | - |
| Icici Prudential Value Discovery Fund | 2.21 | 75066704 | - | - |
| Franklin India Smaller Companies Fund | 1.73 | 75066707 | - | - |
| Smallcap World Fund, Inc | 3.94 | 75066712 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Union Investments Private Limited | 37.41 | 75066693 | 100 | 0 |
| Union (Mauritius) Holdings Limited | 4 | 75066694 | 100 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Hdfc Small Cap Fund | 4.96 | 75066703 |
| Icici Prudential Value Discovery Fund | 2.21 | 75066704 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 2.12 | 75066705 |
| Sbi Contra Fund | 2.01 | 75066706 |
| Franklin India Smaller Companies Fund | 1.73 | 75066707 |
| Smallcap World Fund, Inc | 3.94 | 75066712 |
| Rimco India Limited | 1.98 | 75066714 |
| Rimco (Mauritius) Limited | 10.13 | 75066716 |
| Olympus Capital Asia Investments Limited | 10.1 | 75066717 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Rashid Aslam Bin Mohideen Mammu Haji | 2.25 | 75066727 |
| Shamsudheen Bin Mohideen Mammu Haji | 1.13 | 75066729 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Apr 23, 2024 | 118 | SPECIAL | Apr 23, 2024 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 28, 2024 | Audited Results & Final Dividend | - |
| Apr 12, 2024 | Interim Dividend & Special Dividend | - |
| Feb 08, 2024 | Quarterly Results | - |
| Nov 14, 2023 | Quarterly Results | - |
| Aug 14, 2023 | Quarterly Results | - |
| May 25, 2023 | Audited Results | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 10, 2022 | Quarterly Results | - |
| Aug 11, 2022 | Quarterly Results | - |
| May 24, 2022 | Audited Results | - |
| Feb 08, 2022 | Quarterly Results | - |
| Nov 11, 2021 | Quarterly Results | - |
| Aug 11, 2021 | Quarterly Results | - |
| Jun 22, 2021 | Audited Results | - |
| Feb 09, 2021 | Quarterly Results | - |
| Nov 10, 2020 | Quarterly Results | - |
| Aug 12, 2020 | Quarterly Results | - |
| Jun 23, 2020 | Audited Results | - |
| Feb 11, 2020 | Quarterly Results | - |
| Jan 09, 2020 | Buy Back of Shares | - |
| Nov 12, 2019 | Quarterly Results | - |
| Aug 07, 2019 | Quarterly Results | - |
| May 28, 2019 | Audited Results | - |
| Feb 13, 2019 | Quarterly Results | - |
| Nov 12, 2018 | Quarterly Results | - |
| Aug 14, 2018 | Quarterly Results | - |
| May 21, 2018 | Audited Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
05 Jul 2024
Aster DM Healthcare Ltd - 540975 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG
27 Jun 2024
Aster DM Healthcare Ltd - 540975 - Closure of Trading Window
Please be informed that in compliance with SEBI (PIT) Regulations, 2015 and the Code for Prevention of Insider Trading adopted by the Company, the Trading Window for dealing in securities of the Company shall be closed for the Designated Persons from July 01, 2024 and would be re-opened after 48 hours from the date of announcement / declaration of un-audited financial results (standalone and consolidated) of the Company for the quarter and three months ended June 30, 2024. We request you to kindly take the same on record.
25 Jun 2024
Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 , please be informed that Mr. Farhan Yasin, Vice President - Kerala, Tamil Nadu & Retail Cluster, a Senior Management Personnel of the Company, vide his letter dated 24th June, 2024 tendered his resignation for personal reasons and has also informed that there are no other reasons for his resignation except the reason mentioned in his resignation letter. We request you to kindly take the above said information on record.
24 Jun 2024
Aster DM Healthcare Ltd - 540975 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Olympus Capital Asia Investments Ltd
21 Jun 2024
Olympus Capital Asia sells 9% stake in Aster DM Healthcare for Rs 1,530 cr
Hong Kong-based Olympus Capital Asia on Friday divested a 9 per cent stake in Hospital chain Aster DM Healthcare for Rs 1,530 crore through open market transactions. Investment firm Olympus Capital Asia, through its arm Olympus Capital Asia Investments, offloaded shares of Dubai-based Aster DM Healthcare on BSE. According to the bulk deal data available with BSE, Olympus Capital Asia Investments sold 4.50 crore shares or a 9 per cent stake in Aster DM Healthcare in two tranches. The shares were disposed of within the price range of Rs 340-340.13 apiece, taking the transaction value to Rs 1,530.08 crore. After the latest transaction, the shareholding of Olympus Capital Asia in Aster DM Healthcare has declined to 1.1 per cent from 10.1 per cent. Meanwhile, Franklin Templeton Mutual Fund, the Singapore government and Morgan Stanley Asia Singapore picked up a total of 1.24 crore shares of Aster DM Healthcare. The shares were purchased at an average price of Rs 340, taking the combine
17 Jun 2024
Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Investor Presentation
With reference to the captioned subject, please find enclosed presentation to be made to Investors in the upcoming investor meetings and investor conference. Request you to kindly take the above said information on record.
15 Jun 2024
Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company through its representatives shall be participating in the 'Investec Investor conference' and shall be meeting various investors at Singapore on 19th June, 2024 and at Hong Kong on 20th June, 2024. We request you to kindly take the above information on record.
14 Jun 2024
Aster DM Healthcare Ltd - 540975 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AG
13 Jun 2024
Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Company through its representatives shall be participating in the 'Nuvama Investor conference' and shall be meeting various investors on June 18, 2024 at Mumbai. We request you to kindly take the above information on record.
04 Jun 2024
Aster DM Healthcare Ltd - 540975 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is further to our earlier letter dated May 29, 2024, regarding video/audio recordings of earning call of the Company for the quarter and year ended March 31, 2024, please find enclosed herewith the transcript of the said earnings call.
